Hydrochloric Acid → 1-[4-(4-Oxazolo[5,4-b]pyridin-2-yl-piperazin-1-yl)-pyrimidin-2-yl]-ethanol

HRID 984884Notes

Reaction equation

HRID 984884 reaction equation
C([O:6][C@@H:7]([C:9]1[N:14]=[C:13]([N:15]2[CH2:20][CH2:19][N:18]([C:21]3[O:22][C:23]4[C:28]([N:29]=3)=[CH:27][CH:26]=[CH:25][N:24]=4)[CH2:17][CH2:16]2)[CH:12]=[CH:11][N:10]=1)[CH3:8])(=O)CCC.Cl.[OH-].[Na+]>O1CCOCC1>[N:29]1[C:28]2[C:23](=[N:24][CH:25]=[CH:26][CH:27]=2)[O:22][C:21]=1[N:18]1[CH2:17][CH2:16][N:15]([C:13]2[CH:12]=[CH:11][N:10]=[C:9]([C@H:7]([OH:6])[CH3:8])[N:14]=2)[CH2:20][CH2:19]1

Participants

5

Procedure

To a solution of (R)-1-[4-(4-oxazolo[5,4-b]pyridin-2-yl-piperazin-1-yl)-pyrimidin-2-yl]-ethyl butyrate (prepared according to the method of Example 9, Step B, 11.0 g, 27.6 mmol) in dioxane (11.5 mL) was added concentrated hydrochloric acid (23 mL, 276 mmol). This mixture was stirred at room temperature overnight, neutralized with 6 N aqueous sodium hydroxide, and extracted with chloroform (3×). The combined organic extracts were dried over sodium sulfate, filtered, evaporated, and purified by flash column chromatography (3.5% methanol/chloroform) to give 8.4 g (93%) of the title compound as a white solid. mp: 153-156° C.; 1H NMR (CDCl3, 300 MHz) δ 8.25 (d, 1H), 7.95 (dd, 1H), 7.58 (dd, 1H), 7.15 (dd, 1H), 6.45 (d, 1H), 4.72 (q, 1H), 4.25 (br s, 1H), 3.85-3.82 (c, 8H), 1.51 (d, 3H); MS (CI/NH3) 327 (MH+); [α]D+16.1 (c, 1.0, MeOH).

Workup

  1. extractionextracted with chloroform (3×)
  2. dry with materialThe combined organic extracts were dried over sodium sulfate
  3. filtrationfiltered
  4. customevaporated
  5. custompurified by flash column chromatography (3.5% methanol/chloroform)

Sources & evidence

ORD record
ord-2bf96aa6ab2a47e1abbc86db5b100d84
Source dataset
uspto-grants-2005_03
Patent number
US06869943B2

Reaction notes

Loading…